QY Research, Inc.

Vacuum-Assisted Biopsy Devices Market Is Expected to Reach 1170 Million US$ by 2025 – QY Research

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

 

City of Industry, CA -- (SBWIRE) -- 08/20/2018 -- This report studies the global Vacuum-assisted Biopsy Devices market status and forecast, categorizes the global Vacuum-assisted Biopsy Devices market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Vacuum-assisted biopsy is a minimally invasive procedure that allows for the removal of multiple tissue samples. However, unlike core needle biopsy, which involves several separate needle insertions to acquire multiple samples, the special biopsy probe used during vacuum-assisted biopsy is inserted only once into the breast through a small skin nick made in the skin of the patient's breast.

Vacuum assisted breast biopsy devices have a needle with an aperture that is placed under or within the lesion of interest. A vacuum sucks tissue into the aperture and then the aperture closes to complete tissue acquisition. They tend to be larger needles and because of the vacuum usually obtain larger size tissue samples. Most of the vacuum assisted devices have a separate console that is hooked to the biopsy device with suction tubing. They are ideally used for all stereotactic and MRI guided core biopsies.

The major players are BD, Mammotome and Hologic. BD (C. R. Bard) is the leader competitor in breast biopsy market. C. R. Bard expanded the use of its devices by offering reusable handles for free when disposable needles were purchased. They produce the Vacora® which is a self-contained VABB device, meaning it requires no additional capital equipment.

Mammotome, a Devicor company, is the second leading competitor in the breast biopsy market. Despite the need for an initial investment in expensive capital equipment, the global adoption rate of the company's Mammotome® Legacy biopsy system has been high, which is expected to continue over the forecast period.

The global Vacuum-assisted Biopsy Devices market is valued at 720 million US$ in 2017 and will reach 1170 million US$ by the end of 2025, growing at a CAGR of 6.2% during 2018-2025.

The major manufacturers covered in this report

BD

Mammotome

Hologic

...

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/395371/global-vacuum-assisted-biopsy-devices-market

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

India

Southeast Asia

Other regions (Central & South America, Middle East & Africa)

Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/e3eb87546581a6812f51908b2ee93e5c,0,1

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.